Cargando…
Exploration of Virtual Candidates for Human HMG-CoA Reductase Inhibitors Using Pharmacophore Modeling and Molecular Dynamics Simulations
3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) is a rate-controlling enzyme in the mevalonate pathway which involved in biosynthesis of cholesterol and other isoprenoids. This enzyme catalyzes the conversion of HMG-CoA to mevalonate and is regarded as a drug target to treat hypercholesterole...
Autores principales: | Son, Minky, Baek, Ayoung, Sakkiah, Sugunadevi, Park, Chanin, John, Shalini, Lee, Keun Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875450/ https://www.ncbi.nlm.nih.gov/pubmed/24386216 http://dx.doi.org/10.1371/journal.pone.0083496 |
Ejemplares similares
-
Discovery of Lonafarnib-Like Compounds: Pharmacophore
Modeling and Molecular Dynamics Studies
por: Rampogu, Shailima, et al.
Publicado: (2020) -
Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
por: John, Shalini, et al.
Publicado: (2011) -
Discovery of Non-Peptidic Compounds against Chagas Disease Applying Pharmacophore Guided Molecular Modelling Approaches
por: Rampogu, Shailima, et al.
Publicado: (2018) -
Predictive Modeling
of HMG-CoA Reductase Inhibitory
Activity and Design of New HMG-CoA Reductase Inhibitors
por: Samizo, Shigeyoshi, et al.
Publicado: (2023) -
Dynamic and Multi-Pharmacophore Modeling for Designing Polo-Box Domain Inhibitors
por: Sakkiah, Sugunadevi, et al.
Publicado: (2014)